How to know when you've crossed over to full, freakin' paranoia?? When you read an article like this & immediately envision #Christofascist legislation to grow "abandoned" frozen embryos via artificial wombs so they can become neglected, traumatized kids--oops, I mean properly-educated RW voters. Voila... the next anti-abortion tool. 🤦♀️
Humanity, as well as Earth, don't need this "reproductive machine" envisioned in the classic song, "In The Year 2525"*. Not only the ethical implications are disastrous.
Many richer people will be able to pretty much procreate as they like, combined with existing technologies like #IVF.
Super soldiers of the type of #CaptainAmerica could be mass-produced without much...
AFAIC, birth by a non-mother of this type will, however, also have adverse impacts on the child's immune system, similar to the one's born through a #CesareanSection:
"The results of the studies included indicated that children delivered by cesarean section more commonly developed respiratory tract infections, obesity...
...and the manifestations of asthma than children delivered vaginally." 2)
And the likelihood of serious mental-health issues, just taking as pars pro toto the doubts of many adopted children about their biologic "real" mother.
And then let's get back to Earth 🌎. This planet doesn’t need any more specimen of the type homo sapiens (or its mutations.) The current #ClimateCrisis can easily be attributed to a sole...
...factor, #overpopulation. Earth has been hit by the shockwaves of a #PopulationBomb and is suffering from the explosion's fallout of currently 8 billion people. We have been in #overshoot for decades and are all living on borrowed time, the so-called #PhantomCarryingCapacity of #Earth. 4)
And then there is also yet another ethical dimension, that of #fascist#eugenics. Who decides who will live or what will be procreated #IVF and then carried to term by an #ArtificialWomb?
#Humanity has already messed around enough with #evolution. Some combinations of the human #genome might simply not be meant to...
...produce offspring. Once again, humankind is attempting to play God.
I hardly ever say this, but no, humanity and Earth do not only need this new technology, quite the opposite is true: any such scientific endeavor to create an #ArtificialWomb should be strictly prohibited and severely punished.
I am under no illusion that my opinion will be influential enough to become mainstream.
10 days to go until BSidesPR! We welcome you at the Puerto Rico Convention Center in San Juan on the 12th and 13th of April. If you haven't yet secured your spot, there's still a window of opportunity. Purchase your tickets here: https://www.eventbrite.com/e/bsidespr-tickets-778014290687?aff=oddtdtcreator.
Don't miss out on a distinct conference experience encompassing Cybersecurity, Healthcare, and Biotechnology. See you there!
📣“I am a #scientist, a #PhD student, a mom, a friend, a hockey player.”
🎥1st video of the 3rd season of the Women [& Girls] in #Science series features Gabriela Retamales, doctoral researcher in #Biotechnology at the University of #Luxembourg
The developer of an experimental immunotherapy delivering nanoscale payloads to treat pancreatic cancer says the treatment received fast-track status from the Food and Drug Administration.
A developer of treatments for cancer and autoimmune disorders from stem cells says FDA cleared its request to start a clinical trial of its therapy for systemic lupus erythematosus.
A collaboration between biotechnology and dairy products businesses seeks to identify peptides in milk to form into dietary supplements for people with mood disorders.
A developer of messenger RNA therapies for respiratory and rare diseases says it received clearance to begin a clinical trial in the U.K. for an inhaled treatment for viral lung conditions.
A vaccine delivered with a patch device is shown in a clinical trial to generate neutralizing antibodies against measles and rubella similar to conventional injections.
Researchers from university labs in the U.K. are developing models of brain cell interactions using a company's synthetic human cells derived from stem cells.
A company producing tissue samples in the lab, for drug discovery and preclinical research with robotics and artificial intelligence, raised $38 million in seed funding.